Steward Partners Investment Advisory’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-500
| Closed | -$4K | – | 3389 |
|
|
2022
Q2 | $4K | Hold |
500
| – | – | ﹤0.01% | 2871 |
|
|
2022
Q1 | $4K | Hold |
500
| – | – | ﹤0.01% | 2984 |
|
|
2021
Q4 | $5K | Hold |
500
| – | – | ﹤0.01% | 2846 |
|
|
2021
Q3 | $8K | Hold |
500
| – | – | ﹤0.01% | 2691 |
|
|
2021
Q2 | $8K | Hold |
500
| – | – | ﹤0.01% | 6330 |
|
|
2021
Q1 | $9.74K | Buy |
+500
| New | +$9.74K | ﹤0.01% | 2792 |
|
|
2020
Q4 | – | Sell |
-300
| Closed | -$6K | – | 2999 |
|
|
2020
Q3 | $6K | Buy |
300
+200
| +200% | +$4K | ﹤0.01% | 2324 |
|
|
2020
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 2423 |
|
|
2020
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 2433 |
|
|
2019
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 2381 |
|
|
2019
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 2459 |
|
|
2019
Q2 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 2385 |
|